Sarep­ta goes back to the gene ther­a­py well at Na­tion­wide Chil­dren’s for its lat­est mus­cle-wast­ing pro­gram

Sarep­ta $SRPT is adding a pre­clin­i­cal gene ther­a­py pro­gram to the pipeline, pick­ing it up from their close con­tacts at Na­tion­wide Chil­dren’s Hos­pi­tal. The treat­ment …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER